Characterization of botulinum progenitor toxins by mass spectrometry

Applied and Environmental Microbiology

Volumn 71, Issue 8, 2005, Pages 4478-4486

  Hines, Harry B ^a   Lebeda, Frank ^a   Hale, Martha ^a   Brueggemann, Ernst E ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CHROMATOGRAPHIC ANALYSIS; CHROMATOGRAPHY; MASS SPECTROMETRY; TOXIC MATERIALS;

BOTULINUM TOXIN; NUCLEOTIDES; PROTEIN COMPOSITION; SEROTYPES;

PROTEINS;

BINDING PROTEIN; BOTULINUM TOXIN; FLAGELLIN; NEUROTOXIN BINDING PROTEIN; PEPTIDE DERIVATIVE; PROTEIN ORF X1; TRYPSIN; UNCLASSIFIED DRUG;

MICROBIOLOGY;

ACCURACY; ALKYLATION; AMINO ACID SEQUENCE; ARTICLE; BACTERIAL STRAIN; CHROMATOGRAPHY; CLOSTRIDIUM BOTULINUM; DATA BASE; ELECTROSPRAY MASS SPECTROMETRY; MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; REDUCTION; SEROTYPE; TOXIN ANALYSIS;

AMINO ACID SEQUENCE; BACTERIAL PROTEINS; BOTULINUM TOXINS; CHROMATOGRAPHY; CLOSTRIDIUM BOTULINUM; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; NANOTECHNOLOGY; PROTEIN PRECURSORS; SEROTYPING; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

ABELMOSCHUS; BACTERIA (MICROORGANISMS); CLOSTRIDIUM BOTULINUM;

EID: 23744508421     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.71.8.4478-4486.2005     Document Type: Article

References (35)

1. Aebersold, R. 2003. A mass spectrometric journey into protein and proteome research. J. Am. Soc. Mass Spectrom. 14:685-695.
2. Arnon, S. S., R. Schechter, T. V. Inglesby, D. A. Henderson, J. G. Bartlett, M. G. Ascher, E. Eitzen, A. D. Fine, J. Hauer, M. Lyton, S. Lillibridge, M. T. Osterholm, T. O'Toole, G. Parker, T. M. Perl, P. K. Russel, D. L. Swerdlow, and K. Tonat. 2001. Botulinum toxin as a biological weapon: medical and public health management. JAMA 285:1059-1070.
3. Cai, S., H. K. Sarkar, and B. R. Singh. 1999. Enhancement of the endopeptidase activity of botulinum neurotoxin by its associated proteins and dithiothreitol. Biochemistry 38:6903-6910.
4. ClustalW. http://www.ebi.ac.uk/clustalw/.
5. Dineen, S. S., M. Bradshaw, and E. A. Johnson. 2003. Neurotoxin gene clusters in Clostridium botulinum type A strains: sequence comparision and evolutionary implications. Curr. Microbiol. 46:345-352.
6. East, A. K., J. M. Stacey, and M. D. Collins. 1994. Cloning and sequencing of a hemagglutinin component of the botulinum neurotoxin complex encoded by Clostridium botulinum types A and B. Syst. Appl. Microbiol. 17: 306-312.
7. East, A. K., M. Bhandari, J. M. Stacey, K. D. Campbell, and M. D. Collins. 1996. Organization and phylogenetic interrelationships of genes encoding components of the botulinum toxincomplex in proteolytic Clostridium botulinum type A, B, and F: evidence of chimeric sequences in the gene encoding the nontoxic nonhemagglutinin component. Int. J. Syst. Bacteriol. 46:1105-1112.
8. Fu, F.-N., S. K. Sharma, and B. R. Singh. 1998. A protease-resistant novel hemagglutinin purified from type A Clostridium botulinum. J. Protein Chem. 17:53-60.
9. Fugita, R., Y. Fujinaga, K. Inoue, H. Nakajima, H. Kumon, and K. Oguma. 1995. Molecular characterization of two forms of nontoxic-nonhemagglutinin components of Clostridium botulinum type A progenitor toxins. FEBS Lett. 376:41-44.
10. Fujinaga, Y., K. Inoue, S. Shimazaki, K. Tomochika, K. Tsuzuki, N. Fujii, T. Watanabe, T. Ohyama, K. Takeshi, K. Inoue, and K. Oguma. 1994. Molecular construction of Clostridium botulinum type C progenitor toxin and its gene organization. Biochem. Biophys. Res. Commun. 205:1291-1298.
11. Fujinaga, Y., K. Inoue, S. Watanabe, K. Yokota, Y. Hirai, I. Nagamachi, and K. Oguma. 1997. The haemagglutinin of Clostridium botulinum type C progenitor toxin plays an essential role in binding of toxin to the epithelial cells of guinea pig small intestine, leading to the efficient absorption of the toxin. Microbiology 143:3841-3847.
12. Fujinaga, Y., K. Inoue, T. Nomura, J. Sasaki, J. C. Marvaud, M. R. Popoff, S. Kozaki, and K. Oguma. 2000. Identification and characterization of functional subunits of Clostridium botulinum type A progenitor toxin involved in binding to intestinal microvilli and erythrocytes. FEBS Lett. 467:179-183.
13. Inoue, K., Y. Fujinaga, T. Watanabe, T. Ohyama, K. Takeshi, K. Moriishi, H. Nakajima, K. Inoue, and K. Oguma. 1996. Molecular composition of Clostridium botulinum type A progenitor toxins. Infect. Immun. 64:1589-1594.
14. Johnson, E. A., and M. Bradshaw. 2001. Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective. Toxicon 39:1703-1722.
15. Kouguchi, H., T. Watanabe, Y. Sagane, and T. Ohyama. 2001. Characterization and reconstitution of functional hemagglutinin of the Clostridium botulinum type C progenitor toxin. Eur. J. Biochem. 268:4019-4026.
16. Kouguchi, H., T. Watanabe, Y. Sagane, H. Sunagawa, T. Ohyama. 2002. In vitro reconstitution of the Clostridiium botulinum type D progenitor toxin. J. Biol. Chem. 277:2650-2656.
17. Li, L., B. Li, S. N. Parikh, R. B. Lomenth, and B. R. Singh. 1997. A novel type E Clostridium botulinum neurotoxin progenitor complex. Protein Sci. 6(Suppl. 2):139T.
18. Marvaud, J. C., M. Gilbert, K. Inoue, V. Fujinaga, K. Oguma, and M. R. Popoff. 1998. botR is a positive regulator of botulinum neurotoxin and associated nontoxic protein genes in Clostridium botulinum A. Mol. Microbiol. 29:1009-1018.
19. Nakajima, H., K. Inoue, T. Ikeda, Y. Fujinaga, H. Sunagawa, K. Yakesi, T. Ohyama, T. Watanabe, K. Inoue, and K. Oguma. 1998. Molecular composition of the 16S toxin produced by a Clostridium botulinum type D strain, 1873. Microbiol. Immunol. 42:599-605.
20. Oguma, K., K. Inoue, Y. Fujinaga, K. Yokota, T. Watababe, T. Ohyama, K. Takeshi, and K. Inoue. 1999. Structure and function of Clostridium botulinum progenitor toxin. J. Toxicol. Tox. Rev. 18:17-34.
21. Oguma, K., Y. Fujinaga, and K. Inoue. 1995. Structure and function of Clostridium botulinum toxins. Microbiol. Immunol. 39:161-168.
22. Ohishi, I., and G. Sakaguchi. 1980. Oral toxicities of Clostridium botulinum type C and D toxins of different molecular sizes. Infect. Immun. 28:303-309.
23. Sagane, Y., T. Watanabe, H. Kouguchi, H. Sunagawa, S. Obata, K. Oguma, and T. Ohyama. 2002. Spontaneous nicking in the nontoxic-nonhemagglutinin component of the Clostridium botulinum toxin complex. Biochem. Biophys. Res. Commun. 292:434-440.
24. Sakaguchi, G. 1983. Clostridium botulinum toxins. Pharmacol. Ther. 19:165-194.
25. Shunji, S., I. Ohishi, and G. Sakaguchi. 1977. Intestinal absorption of botulinum toxins of different molecular sizes in rats. Infect. Immun. 17:491-496.
26. Singh, B. R. 2000. Intimate details of the most poisonous poison. Nat. Struct. Biol. 7:617-619.
27. 1, and E produce proteins with or without hemagglutinating activity: do they share common amino acid sequences and genes? J. Protein Chem. 10:415-425.
28. van Baar, B. L. M., A. G. Hulst, and E. R. J. Wils. 2002. Characterisation of tetanus toxin, neat and in culture supernatant, by electrospray mass spectrometry. Anal. Biochem. 301:278-289.
29. van Baar, B. L. M., A. G. Hulst, A. L. de Jong, and E. R. J. Wils. 2002. Characterisation of botulinum toxins type A and B, by matrix-assisted laser desorption ionisation and electrospray mass spectrometry. J. Chromatogr. A 970:95-115.
30. van Baar, B. L. M., A. G. Hulst, A. L. de Jong, and E. R. J. Wils. 2004. Characterisation of botulinum toxins type C, D, E, and F by matrix-assisted laser desorption ionisation and electrospray mass spectrtometry. J. Chromatogr. A 1035:97-114.
31. Watanabe, T., Y. Sagane, H. Kouguchi, H. Sunagawa, K. Inoue, Y. Fujinaga, K. Oguma, and T. Ohyama. 1999. Molecular composition of progenitor toxin produced by Clostridium botulinum type C strain 6813. J. Protein Chem. 18:753-760.
32. Weller, U., M.-E. Dauzenrothe, D. Meyer zu Heringdorf, and E. Habermann. 1989. Chains and fragments of tetanus toxin. Separation, reassociation, and pharmacological properties. Eur. J. Biochem. 182:649-656.
33. Zhang, L., W.-J. Lin, S. Li, and R. Aoki. 2003. Complete DNA sequences of the botulinum neurotoxin complex of Clostridium botulinum type A-Hall (Allergan) strain. Gene 315:21-32.
34. Zhang, Z., and B. R. Singh. 1995. A novel complex of type E Clostridium botulinum. Protein Sci. 4(Suppl. 2):110.
35. Zilinskas, R. A. 1997. Iraq's biological weapons. The past as future? JAMA 278:418-424.